Intraabdominal hypertension (IAH) and abdominal compartment syndrome (ACS), the pathophysiologic implications of elevated intraabdominal pressure (IAP), have detrimental effects on all organ systems and are associated with significant morbidity and mortality. Within the past few years, the diagnosis and management of these syndromes have evolved tremendously.
Introduction
Intraabdominal hypertension (IAH) and abdominal compartment syndrome (ACS), the pathophysiologic manifestations of elevated intraabdominal pressure (IAP), represent significant causes of morbidity and mortality [1-9,10 -22 ]. Implementation of bedside IAP monitoring, creation of consensus definitions and recommendations, and application of an evolving management strategy have resulted in significant improvements in patient survival [23,24 ,25 ,26 ] . The incidence of IAH/ACS, principles and techniques for IAP monitoring, and current fluid resuscitation guidelines were recently reviewed in this journal [27 ] . The following complementary article addresses state-of-the-art management of patients with IAH/ACS and identifies recent cuttingedge improvements.
Current management of intraabdominal hypertension/abdominal compartment syndrome
The multiple disparate patient populations at risk for IAH/ACS, combined with numerous causative factors, make a standardized therapeutic approach to these complex patients difficult. Several fundamental management principles, however, remain constant across all patient populations. Although surgical decompression is widely and erroneously considered the only treatment for IAH/ ACS, nonoperative medical management strategies play a vital role in the prevention and treatment of IAP-induced organ dysfunction and failure [6-8,10 ,27 ,28,29 ] . Appropriate management of IAH/ACS is based upon four general principles:
(1) serial monitoring of IAP, (2) optimization of systemic perfusion and organ function, (3) institution of specific medical interventions to reduce IAP and the end-organ consequences of IAH/ACS, (4) prompt surgical decompression for refractory IAH.
Over 200 clinical trials, case reports/series, or review articles on IAH/ACS have been published within the past 2 years. The consensus definitions and recommendations recently published by the World Society of the Abdominal Compartment Syndrome (WSACS) represent a summation of our current understanding of IAH/ACS (Tables 1 and 2 ). On the basis of these recommended standards, the WSACS has developed both a diagnostic and a therapeutic algorithm for patient management (Figs 1 and 2) . These recommendations and algorithms will be briefly reviewed along with recently published developments.
Risk factors for and surveillance of intraabdominal hypertension/abdominal compartment syndrome IAH and ACS have been witnessed to occur in virtually all patient populations [2,4-6,9,10 ,17 ,18 ,20 ,22 ,25 , 26 ,29 ,30 ,31,32 ] . Although numerous risk factors have been identified ( Fig. 1 ), independent predictors of IAH/ ACS include hypothermia, acidosis (elevated base deficit, elevated lactate, or high gastric regional devoid of endtidal carbon dioxide tension), anemia, oliguria, abdominal surgery, abdominal trauma, high-volume fluid resuscitation (>3500 ml/24 h), ileus, and pulmonary, renal, or liver dysfunction [2, 4, 7, 12 ] . Recently, the development of IAH has been identified as an independent predictor of the need for reexploration for intraabdominal catastrophe (abscess, intestinal ischemia, and perforation)
Abdominal compartment syndrome Cheatham 155 IAP should be expressed in mmHg and measured at end-expiration in the complete supine position after ensuring that abdominal muscle contractions are absent and with the transducer zeroed at the level of the mid-axillary line. Definition 5
The reference standard for intermittent IAP measurement is via the bladder with a maximal instillation volume of 25 ml of sterile isotonic saline.
Definition 6
Normal IAP is approximately 5-7 mmHg in critically ill adults. Definition 7 IAH is defined by a sustained or repeated pathologic elevation of IAP at least 12 mmHg. Definition 8 IAH is graded as follows: Grade I: IAP 12-15 mmHg  Grade II: IAP 16-20 mmHg  Grade III: IAP 21-25 mmHg  Grade IV: IAP >25 mmHg  Definition 9 ACS is defined as a sustained IAP more than 20 mmHg (with or without an APP < 60 mmHg) that is associated with new organ dysfunction/failure.
Definition 10
Primary ACS is a condition associated with injury or disease in the abdominopelvic region that frequently requires early surgical or interventional radiological intervention.
Definition 11
Secondary ACS refers to conditions that do not originate from the abdominopelvic region.
Definition 12
Recurrent ACS refers to the condition in which ACS redevelops following previous surgical or medical treatment of primary or secondary ACS.
ACS, abdominal compartment syndrome; APP, abdominal perfusion pressure; GFP, glomerular filtration pressure; IAH, intraabdominal hypertension; IAP, intraabdominal pressure; MAP, mean arterial pressure; PTP, proximal tubular pressure. Insufficient data exist to make recommendations at this time.
The Grade scheme (www.gradeworkinggroup.org) classifies recommendations as either strong recommendations (Grade 1) or weak suggestions (Grade 2) according to the balance between the associated benefits and risks. The quality of evidence is classified as high (Grade A), moderate (Grade B), or low (Grade C) according to the study design, consistency of results, and directness of the evidence (the similarity of the study patients to the population of interest). As a result, a strong recommendation based upon high-quality evidence will receive a Grade of '1A', whereas a weak suggestion based upon low-quality evidence will receive a Grade of '2C'. ACS, abdominal compartment syndrome; APP, abdominal perfusion pressure; IAH, intraabdominal hypertension; IAP, intraabdominal pressure; NMB, neuromuscular blockade. IAP is most commonly determined using the intravesicular or 'bladder' technique, which has been well described [23,24 ,27 ,34,38] . The recent literature, however, has addressed several important issues, which bear consideration. Although an isotonic saline instillation volume of no more than 25 ml is widely recognized as being optimal, volumes as low as 2-3 ml have been demonstrated to be accurate and volumes more than 25 ml potentially misleading by overestimating IAP [39 ] . The optimal frequency of IAP monitoring has yet to be determined, although measurements every 4-6 h are now commonplace in many ICUs. IAP clearly varies with respiration, should be measured at endexpiration, and may be useful as a marker of abdominal wall compliance [40 ] . IAP also varies with BMI such that obese patients have a higher baseline IAP [41 ] . As a result, obesity-induced increases in IAP should be considered when evaluating patients for IAH/ACS. The temperature of the isotonic saline instilled is also important; room temperature (RT) isotonic saline significantly increases IAP, presumably due to contraction of the bladder detrusor muscle, potentially leading to a falsely elevated IAP [42 ] . Waiting 30-60 s after isotonic saline instillation to allow warming of the fluid and relaxation of the detrusor muscle has thus been recommended [23, 24 ] .
A recent multicenter international trial evaluated three different zero reference transducer positions for IAP measurement (pubic symphysis, phlebostatic axis, and mid-axillary). The authors found that there can be considerable variation in determining the exact location of both the phlebostatic axis and the symphysis pubis clinically resulting in differing IAP values [43 ] . They concluded that IAP transducers should be zeroed at the mid-axillary line to ensure consistency from measurement to measurement.
IAP monitoring has traditionally been performed in the supine position. Several recent studies [44 ,45-50] have evaluated the impact of head of bed elevation (to prevent ventilator-associated pneumonia) upon IAP measurements. These studies have routinely found that head of bed elevation significantly increases IAP compared with supine measurements. Such increases in IAP become clinically significant (increase >2 mmHg) when the patient's head of bed exceeds 208 elevation. Consequently, traditional supine IAP measurements may underestimate the patient's true IAP if the head of bed is being elevated between measurements. Prone positioning for acute lung injury has also been demonstrated to significantly increase IAP. Although some authors believe such increases are due to visceral bladder compression as a result of gravity, intragastric pressures are also increased by head of bed elevation, suggesting that this is a true physiologic and clinically important effect [47] . As clinical decision thresholds for nonsupine IAP measurements have not yet been defined, until further research is available, IAP measurements should be performed in the supine position and the potential contribution of body position considered when interpreting IAP measurements [24 ,27 ] .
Other techniques for IAP determination are gaining acceptance. Intragastric balloon catheters, direct intraabdominal catheters, and noninvasive IAP estimation using near-infrared spectroscopy have all been described and validated against the traditional intravesicular method [51] [52] [53] . Continuous IAP measurement has been demonstrated to be an accurate and clinically useful monitoring technology, although superiority over intermittent measurements has not been established [51,54 ,55,56] .
Ejike et al. [57 ] , in a landmark paper, addressed an important question: what is the normal range of IAP among critically ill infants and children? They confirmed that 3 ml of isotonic saline represents the minimal instillation volume necessary to measure IAP in children below 20 kg body weight. The WSACS currently recommends an instillation volume of 1 ml/kg up to 20 kg, which is within the ranges supported by the Ejike et al. study [58] .
Abdominal perfusion pressure
The 'critical IAP' that causes end-organ dysfunction or failure varies from patient to patient as a result of differences in physiology and preexisting comorbidities. It may be inappropriate, therefore, to assume that a single threshold IAP can be applied to the clinical decisionmaking of all patients. 'Abdominal perfusion pressure' (APP), defined as mean arterial pressure (MAP) devoid of IAP, assesses not only the severity of IAP present but also the relative adequacy of abdominal blood flow [59] . APP has been demonstrated in multiple studies to be superior to IAP measurements alone [30 ,59] . Failure to maintain an APP of at least 60 mmHg has been found to discriminate between survivors and nonsurvivors and appears to be a useful resuscitation endpoint [59] . Maintenance of an APP of at least 60 mmHg, achieved through a balance of judicious fluid resuscitation and application of vasoactive medications, has been demonstrated to reduce the incidence of acute renal failure in two recent studies [30 ,60 ] . The WSACS is currently subjecting APPdirected resuscitation to a prospective, randomized, multicenter trial. 
Diuretics and continuous venovenous hemofiltration/ ultrafiltration
Early intermittent hemodialysis or continuous hemofiltration/ultrafiltration may be more appropriate than continuing to volume load and increase the likelihood of secondary ACS with its attendant morbidity and mortality [69 ] . Diuretic therapy, in combination with colloid, may also be considered to mobilize third-space edema once the patient is hemodynamically stable [67 ] .
Percutaneous decompression
Percutaneous catheter drainage of free intraabdominal fluid, air, abscess, or blood is an effective technique for reducing IAP and potentially correcting IAH-induced organ dysfunction [67 ,70] . Performed under ultrasound or computed tomography guidance, percutaneous decompression can significantly reduce IAP and decrease the need for morbidity of surgical decompression. This minimally invasive approach to IAH/ACS management is most effective in patients with secondary ACS due to excessive resuscitation, burns, acute pancreatitis, or ascites. Patients with IAH/ACS refractory to percutaneous catheter decompression should undergo abdominal decompression.
Abdominal decompression
Surgical decompression of the abdomen has long been the standard treatment for IAH/ACS and can be lifesaving when a patient's organ dysfunction, failure, or both are refractory to medical treatment [10 ,71] . Delayed abdominal decompression and disregard of high IAP levels are associated with significant increases in patient mortality [18 , 59, 72 ] . 'Prophylactic' decompression and creation of a 'temporary abdominal closure' in surgical patients at risk for IAH/ACS significantly reduces the subsequent development of IAH/ACS and improves survival [25 ] . Although seemingly aggressive and potentially disabling, patients at risk for IAH/ACS who are treated with prophylactic decompression demonstrate identical long-term physical and mental health function as well as resumption of gainful employment compared with similar patients who undergo primary fascial closure [73 ] .
A variety of different methods ['vacuum-pack closure', 'Bogota bag' or silo, Velcro burr, absorbable mesh, and vacuum-assisted closure (VAC)] have been described for managing the 'open abdomen' [71,74 -77 ] . No one technique demonstrates superiority in all clinical situations and a surgeon must be familiar with the relative benefits of indications for each method. It is essential to recognize that recurrent ACS is possible with any of these techniques, especially if applied in a fashion that does not allow continued visceral expansion during resuscitation [9, 33 ,71] . If recurrent ACS develops, the dressing should be immediately removed and reapplied so as to reduce IAP to an acceptable level [77 ] .
Leppäniemi et al. [78] have recently described subcutaneous release of the linea alba as a less invasive technique for abdominal decompression in patients with acute pancreatitis. This technique reduces IAP and restores organ function while maintaining the skin and peritoneum intact for visceral protection. This technique has recently been shown to be an effective alternative to open decompression in the traumatically injured as well [79 ] .
Definitive abdominal closure
Following surgical decompression and resolution of the patient's ACS, the next therapeutic goal should be definitive closure of the patient's abdomen. Most patients, if decompressed early prior to development of significant organ failure, will tolerate primary fascial closure within 5-7 days. Cheatham and Safcsak [25 ] recently reported an 80% same admission primary fascial closure rate among patients decompressed for IAH/ACS. Those patients who remain critically ill past this time period with significant loss of abdominal domain will likely require either split-thickness skin grafting of the exposed viscera, with subsequent fascial closure 9-12 months later, or cutaneous advancement flap ('skin-only') closure, which allows fascial closure after only 3-6 months [25 , 59, 71] .
Conclusion
The diagnosis and management of IAH/ACS is evolving at a rapid rate. Liberal IAP measurement in the presence of known risk factors, implementation of comprehensive medical interventions to reduce elevated IAP, earlier surgical decompression, and aggressive attempts to achieve primary fascial closure following resolution of a patient's critical illness have resulted in significant improvements in both short and long-term outcome for patients who develop IAH/ACS. All clinicians should be aware of the risk factors that predict development of IAH/ ACS, the appropriate measurement of IAP, and the current resuscitation options for managing these highly morbid syndromes. IAH was an independent risk factor for death (OR 2.5). Patients with IAH demonstrated significantly higher ICU and 90-day mortality. Mortality among patients with primary IAH was significantly higher than for those with secondary IAH. 
